| Risk of HIV transmission through condomless sex in serodifferent gay couples with the HIV-positive partner taking suppressive antiretroviral therapy (PARTNER): final results of … AJ Rodger, V Cambiano, T Bruun, P Vernazza, S Collins, O Degen, ... The Lancet 393 (10189), 2428-2438, 2019 | 1021 | 2019 |
| Impact on life expectancy of HIV-1 positive individuals of CD4+ cell count and viral load response to antiretroviral therapy MT May, M Gompels, V Delpech, K Porter, C Orkin, S Kegg, P Hay, ... Aids 28 (8), 1193-1202, 2014 | 702 | 2014 |
| Major clinical outcomes in antiretroviral therapy (ART)–naive participants and in those not receiving ART at baseline in the SMART study Strategies for Management of Antiretroviral Therapy (SMART) Study Group The Journal of infectious diseases 197 (8), 1133-1144, 2008 | 576 | 2008 |
| British HIV Association Guidelines for the treatment of HIV-1-infected adults with antiretroviral therapy 2008 BG Gazzard, J Anderson, A Babiker, M Boffito, G Brook, G Brough, ... HIV medicine 9 (8), 563-608, 2008 | 524 | 2008 |
| Impact of late diagnosis and treatment on life expectancy in people with HIV-1: UK Collaborative HIV Cohort (UK CHIC) Study M May, M Gompels, V Delpech, K Porter, F Post, M Johnson, D Dunn, ... Bmj 343, 2011 | 476 | 2011 |
| Predicting the risk of cardiovascular disease in HIV-infected patients: the data collection on adverse effects of anti-HIV drugs study N Friis-Møller, R Thiebaut, P Reiss, R Weber, A D'Arminio Monforte, ... European journal of cardiovascular prevention & rehabilitation 17 (5), 491-501, 2010 | 437 | 2010 |
| British HIV Association guidelines for the treatment of HIV‐1‐positive adults with antiretroviral therapy 2012 (Updated November 2013. All changed text is cast in yellow … Writing Group, I Williams, D Churchill, J Anderson, M Boffito, M Bower, ... HIV medicine 15, 1-6, 2014 | 419 | 2014 |
| A randomized comparative trial of tenofovir DF or abacavir as replacement for a thymidine analogue in persons with lipoatrophy GJ Moyle, CA Sabin, J Cartledge, M Johnson, E Wilkins, D Churchill, ... Aids 20 (16), 2043-2050, 2006 | 347 | 2006 |
| British HIV Association (BHIVA) guidelines for the treatment of HIV-infected adults with antiretroviral therapy S Collins, M Fisher, M Johnson, S Khoo, C Leen, C Loveday, G Moyle, ... | 324* | 2003 |
| Inferior Clinical Outcome of the CD4+ Cell Count–Guided Antiretroviral Treatment Interruption Strategy in the SMART Study: Role of CD4+ Cell Counts and HIV … Strategies for Management of Antiretroviral Therapy (SMART) Study Group The Journal of infectious diseases 197 (8), 1145-1155, 2008 | 259 | 2008 |
| British HIV Association (BHIVA) guidelines for the treatment of HIV-infected adults with antiretroviral therapy (2006) B Gazzard, AJ Bernard, M Boffito, D Churchill, S Edwards, N Fisher, ... HIV medicine 7 (8), 487-503, 2006 | 251 | 2006 |
| British HIV Association guidelines for antiretroviral treatment of HIV seropositive individuals BG Gazzard, GJ Moyle, J Weber, M Johnson, JS Bingham, R Brettle, ... The Lancet 349 (9058), 1086-1092, 1997 | 228 | 1997 |
| Efficacy and safety of atazanavir-based highly active antiretroviral therapy in patients with virologic suppression switched from a stable, boosted or unboosted protease … J Gatell, DS Ceron, A Lazzarin, EV Wijngaerden, F Antunes, C Leen, ... Clinical Infectious Diseases 44 (11), 1484-1492, 2007 | 202 | 2007 |
| Risk for opportunistic disease and death after reinitiating continuous antiretroviral therapy in patients with HIV previously receiving episodic therapy: a randomized trial SMART Study Group* Annals of internal medicine 149 (5), 289-299, 2008 | 167 | 2008 |
| Consensus statement on diagnosis, investigation, treatment and prevention of acute bacterial meningitis in immunocompetent adults N Begg, KAV Cartwright, J Cohen, EB Kaczmarski, JA Innes, CLS Leen, ... Journal of infection 39 (1), 1-15, 1999 | 164 | 1999 |
| Fluconazole resistant Candida in AIDS. R Fox, KR Neal, CLS Leen, ME Ellis, BK Mandal | 163 | 1991 |
| Factors influencing efavirenz and nevirapine plasma concentration: effect of ethnicity, weight and co-medication W Stöhr, D Back, D Dunn, C Sabin, A Winston, R Gilson, D Pillay, T Hill, ... Antiviral therapy 13 (5), 675-685, 2008 | 158 | 2008 |
| British HIV Association (BHIVA) guidelines for the treatment of HIV-infected adults with antiretroviral therapy (2005). B Gazzard HIV medicine 6, 2005 | 149 | 2005 |
| UK consensus guidelines for the use of the protease inhibitors boceprevir and telaprevir in genotype 1 chronic hepatitis C infected patients P Ramachandran, A Fraser, K Agarwal, A Austin, A Brown, GR Foster, ... Alimentary pharmacology & therapeutics 35 (6), 647-662, 2012 | 136 | 2012 |
| Rate of AIDS diseases or death in HIV-infected antiretroviral therapy-naive individuals with high CD4 cell count UK Collaborative HIV Cohort (CHIC) Study Steering Committee Aids 21 (13), 1717-1721, 2007 | 133 | 2007 |
